Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (86)

Latest Posts

About This Stock More About This Stock
ASCO Abstracts Week: Biotech Trends And Hot Stocks
Article By: Rod Raynovich
Monday, May 22, 2017 10:58 PM EDT
Today Amgen was down over 2 % on news that its osteoporosis treatment Evenity is unlikely to win FDA approval this year because of a safety risk. Radius Health was up over 6% to $37.30 as their rival drug Tymlos was approved in April.
In this article: MRK, ALNY, IBB, INCY, REGN, AMGN, CLVS, VRTX, FBT, XBI, PUMA, JUNO, EPZM, GLYC, KITE, BLUE, RDUS
Read
Incyte Rises After ASCO Abstracts, But Piper Urges Closer Look
Article By: The Fly
Wednesday, May 17, 2017 9:48 PM EDT
The release of study abstracts for next month's ASCO conference drove significant moves tonight in drugmakers, but Piper Jaffray urged caution on the company's data, saying its "not sure what other investors are seeing that we aren't."
In this article: MRK, INCY, NLNK, AMGN, NKTR, CYTR, BLUE, LBIO, LPTX
Read
Large Cap Biopharmaceutical Valuations: Q1 2017
Article By: Rod Raynovich
Monday, May 8, 2017 8:45 PM EDT
Large cap biopharmaceutical stocks are about 3-4% off their 2017 highs but have been losing momentum. Here is a quick review of the valuation metrics.
In this article: BMY, RHHBY, FBIOX, ALXN, IBB, REGN, AMGN, BIIB, CELG, GILD, FBT, XBI, ABBV
Read
Biotech Bonanza – Approaching An Inflection Point
Article By: Tarun Chandra, CFA
Saturday, May 6, 2017 6:42 PM EDT
Biotechs are performing well this year even in an uncertain environment. Policy clarity is important and we may be approaching an inflection point for them to push higher. Investors should maintain exposure to this volatile but promising sector.
In this article: IBB, SPY, XBI, ALXN, AMGN, BIIB, CELG, BIVV, LLY, MRK, PFE, INCY, GILD, SRPT
Read
Celgene Vs. Amgen: Which Stock Is A Better Pick Post Q1 Earnings?
Article By: Arpita Dutt
Wednesday, May 3, 2017 2:44 PM EDT
Last week, two major names in the biotech sector reported first quarter 2017 results -- Amgen, Inc. and Celgene Corporation. Here is a look at how both companies fared in the first quarter and which one looks better-positioned.
In this article: AMGN, CELG
Read

PARTNER HEADLINES

Latest Tweets for $AMGN

No tweets yet!